Health

Lilly Asia Ventures is among the participants in a series A round for the lung cancer drug developer that could potentially reach $150m.

GlaxoSmithKline, Johnson & Johnson and DaVita HealthCare Partners had invested in the medical device provider before it floated above its range.

Ipreo and Barclays-backed financial communication technology developer OpenExchange raised $23m while Blue Cross Blue Shield, Optum and Marshfield Clinic are set to exit Contessa Health.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

UK Innovate will unite the Office of Technology Commercialization and several other initiatives as the university reveals it launched six new spinouts.

The GV-backed medical supplies distribution service received the money from new and returning investors at a $2.75bn valuation.

SBCVC helped supply $46.5m for smart industrial software developer Ones while e-commerce marketplace aggregator 10club raised $40m in a PDC and HeyDay-backed seed round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The diagnostic and therapeutic isotope producer secured series C-5 funding, which will be used to accelerate the development of new fusion-based technology applications.

Gilead Sciences is co-leading a $75m PIPE deal for the coronavirus drug developer, which is set take the place on Nasdaq held by FS Development Corp II later this year.